within Pharmacolibrary.Drugs.ATC.A;

model A01AB13
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.77,
    Cl             = 0.6,
    adminDuration  = 600,
    adminMass      = 0.5,
    adminCount     = 1,
    Vd             = 0.0013,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.009833333333333333,
    Tlag           = 1020
  );

  annotation(Documentation(
    info ="<html><body><p>Tetracycline is a broad-spectrum antibiotic used to treat a wide array of bacterial infections, including respiratory tract infections, urinary tract infections, and certain sexually transmitted diseases. It works by inhibiting protein synthesis in bacteria. Though widely used in the past, tetracycline use has declined due to bacterial resistance and newer antibiotics. It is still sometimes prescribed today, but more modern tetracyclines are generally preferred.</p><h4>Pharmacokinetics</h4><p>Reported population pharmacokinetic parameters in healthy adult volunteers, generally after oral administration.</p><h4>References</h4><ol><li><p>Mergenhagen, KA, et al., &amp; Russo, TA (2020). Fact versus Fiction: a Review of the Evidence behind Alcohol and Antibiotic Interactions. <i>Antimicrobial agents and chemotherapy</i> 64(3) –. DOI:<a href=&quot;https://doi.org/10.1128/AAC.02167-19&quot;>10.1128/AAC.02167-19</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/31871085/&quot;>https://pubmed.ncbi.nlm.nih.gov/31871085</a></p></li><li><p>Tao, RE, et al., &amp; Feldman, SR (2023). Oral Tetracycline-Class Drugs in Dermatology: Impact of Food Intake on Absorption and Efficacy. <i>Antibiotics (Basel, Switzerland)</i> 12(7) –. DOI:<a href=&quot;https://doi.org/10.3390/antibiotics12071152&quot;>10.3390/antibiotics12071152</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/37508248/&quot;>https://pubmed.ncbi.nlm.nih.gov/37508248</a></p></li><li><p>Rodvold, KA, &amp; Pai, MP (2019). Pharmacokinetics and Pharmacodynamics of Oral and Intravenous Omadacycline. <i>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</i> 69(Suppl 1) S16–S22. DOI:<a href=&quot;https://doi.org/10.1093/cid/ciz309&quot;>10.1093/cid/ciz309</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/31367744/&quot;>https://pubmed.ncbi.nlm.nih.gov/31367744</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end A01AB13;
